[ Back to EurekAlert! ]

Contact: Edyta Zielinska
edyta.zielinska@jefferson.edu
215-955-5291
Thomas Jefferson University

Dr. Massimo Cristofanilli Discusses the Value of Genomic Testing for Early Stage Breast Cancer

Loading video...

Caption: Genomic tests that determine the molecular subtype of a woman's breast cancer provide a more precise prognosis and valuable guidance on treatment options, according to recent research presented this year at the San Antonio Breast Cancer Symposium (SABCS).

Credit: Thomas Jefferson University

Usage Restrictions: None

Related news release: Breast cancer treatment selection is improved by genomic tests at Jefferson Breast Care Center


[ Back to EurekAlert! ]